Navigation Links
DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
Date:2/11/2013

cal facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company's ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company's products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, clinical studies and future product commercialization; and, the Company's business, research, product development, regulatory approval, marketing and distribution plans and strategies. These and other factors are identified and described in more detail in our filings with the SEC, including, our current reports on Form 8-K. We do not undertake to update these forward-looking statements made by us.

For further information, please visit www.delmarpharma.com;   
or contact Jeffrey A. Bacha , President & CEO  (604) 629-5989


'/>"/>
SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)...  Bayer Corporation hosted its annual "Take Your Child to ... US headquarters.  This is Bayer,s second "Take Your Child To ... campus, and Thursday,s event welcomed 230 children ready to ... Fortunately, for the kids, this was not just ... is "Science For A Better Life," Bayer made sure that ...
(Date:4/24/2015)... CHAPEL HILL, N.C. , April 24, 2015 ... marketplace, organizations are establishing employee groups around the ... workforce and round-the-clock business hours. While there are ... becoming global, leaders must examine which best practices ... global operational excellence. According to ...
(Date:4/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) has ... 2015-2019" report to their offering. The ... a CAGR of 7.07% over the period 2014-2019 ... two segments: Equipment and Consumables. This report covers the ... Biobanking market for the period 2015-2019. ...
Breaking Medicine Technology:Bayer Hosts "Take Your Child to Work Day" 2Bayer Hosts "Take Your Child to Work Day" 3Bayer Hosts "Take Your Child to Work Day" 4Work Around the Clock: Building Effective Global Capabilities 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2
... ANGELES, Oct. 13, 2011 IVD Technology ... in vitro diagnostics technologies including research, development, and manufacturing, ... most significant emerging trend in the industry ... (CONTACT:   http://photos.prnewswire.com/prnh/20101214/LA16070LOGO ) The ...
... Oct. 13, 2011 PharmAthene, Inc. (NYSE Amex: ... brief in response to SIGA Technologies, motion for reargument.  On ... Chancery had issued a ruling in its litigation against SIGA ... years from all sales of ST-246 and related products after ...
Cached Medicine Technology:Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 2Distinguished Speaker Dr. Elizabeth Mansfield Joins IVD Technology for Upcoming Webcast: The Regulation of Companion Diagnostics: Current Status and Updates 3PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 2PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument 3
(Date:4/25/2015)... York New York (PRWEB) April 25, 2015 ... that Dr. Jerry Blaivas has been chosen by the New ... for his contributions to medicine in the field of Urology. ... the best in his speciality, Genito-Urinary diseases. He was ... specifically in the field of urology. Not only did ...
(Date:4/25/2015)... On Friday, April 17, Interstate Batteries ... Best Implementation Award. This award is given to ... of RFID technology to improve its manufacturing, supply chain ... best demonstrates how RFID is delivering real value to ... Live! 2015 in San Diego, the RFID industries annual ...
(Date:4/24/2015)... CA (PRWEB) April 24, 2015 Bird B ... and residential applications now offers a complete line of bird ... to poultry farms. , New Flu Strains Threaten Pacific, Central ... 2015 USDA post , a number of highly pathogenic ... paths. The disease is often spread when wild birds enter ...
(Date:4/24/2015)... April 24, 2015 Multi Customer Discount ... tank pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in ... the program. This does not include any Dig fees, ... $25-$65 per person. If someone is part of this ... tanks totaling approximately 2500 gallons or more, the cost ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Ryadon is ... wide range of capabilities and services to complement any ... Ryadon's Quantity Discount Program will be offered on all ... , Order 4-19: Receive 10% discount - Order 20+: ... Using the Drawer Slides Products, ...
Breaking Medicine News(10 mins):Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 2Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 3Health News:Bird B Gone Offers Solutions to Bird Flu Threat to Poultry Farms 4Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3
... the 25 years since establishing the Dyslexia Research Laboratory ... MD, has witnessed a dramatic transformation in thinking among ... years, there have been a host of explanations offered ... of Behavioral Neurology at BIDMC whose work has played ...
... Oct. 17 SuperGen Inc.,(Nasdaq: SUPG ), ... and commercialization of therapies for solid tumors and,hematological ... for poster presentations at the AACR-NCI-EORTC International,Conference from ... Francisco. The poster presentations will focus on ...
... platform that,leverages data contained within enterprise healthcare systems into clinical, intelligence ... ... costs, PHILADELPHIA, ... availability of the NDMA Clinical,Intelligence Platform to all healthcare providers around ...
... ATLANTA, Oct. 17 After completing its review ... Data Safety,Monitoring Board (DSMB) has recommended that the ... Diabetic Macular Edema) Study,continue under the current protocol, ... Medidur FA for the treatment of diabetic macular ...
... physician,you hear all sorts of excuses for not getting ... of First Coast Family Medicine and clinical,spokesperson for Jacksonville,s ... Dr. Hashey reports is the excuse that people always,get ... farther from the truth.,The flu shot is safe and ...
... Systems,Incorporated (Nasdaq: IMCL ) and Bristol-Myers Squibb ... have established an agreement with Merck KGaA for,the ... the terms of the agreement, ImClone Systems, Bristol-Myers,Squibb ... effort to develop and,following regulatory approval, market ERBITUX ...
Cached Medicine News:Health News:BIDMC Dyslexia Research Lab celebrates 25th anniversary 2Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 2Health News:SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference 3Health News:NDMA Launches Clinical Intelligence Platform 2Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 2Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 3Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 4Health News:Flu Myths Abound in Flu Season 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 3Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 4Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 5Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 6Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 7
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Direct has been selling replacement ... 1996, and we are extremely ... guarantee. Check out our catalog ... our discount light bulbs specials. ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
Medicine Products: